MUCUS RELIEF DM EXTENDED RELEASE CAPLETS (Guaifenesin, Dextromethorphan Hbr) Tablet [Cardinal Health (Leader) 70000]

COMPARE TO MUCINEX® DM MAXIMUM STRENGTH active ingredients* Maximum strength Mucus Relief DM Dextromethorphan HBr, 60 mg Guaifenesin, 1200 mg Cough Suppressant Expectorant 12 Hour Relief Controls Cough Thins and Loosens Mucus EXTENDED-RELEASE TABLETS *This product is not manufactured or distributed Reckitt Benckiser LLC, distributor Mucinex® DM Maximum Strength. TAMPER EVIDENT: DO NOT USE IF BLISTER UNIT IS TORN, BROKEN OR SHOWS ANY SIGNS OF TAMPERING. KEEP OUTER CARTON FOR COMPLETE WARNINGS AND PRODUCT INFORMATION. DISTRIBUTED BY CARDINAL HEALTH DUBLIN, OHIO 43017 www.myleader.com Close …

TOPIRAMATE Tablet, Film Coated [PD-Rx Pharmaceuticals, Inc.]

The following serious adverse reactions are discussed in more detail in other sections of the labeling:• Acute Myopia and Secondary Angle Closure Glaucoma [see Warnings and Precautions  (5.1)] • Visual Field Defects [see Warnings and Precautions (5.2)] • Oligohidrosis and Hyperthermia [see Warnings and Precautions (5.3)] • Metabolic Acidosis [see Warnings and Precautions (5.4)] • Suicidal Behavior and Ideation [see Warnings and Precautions (5.5)] • Cognitive/Neuropsychiatric Adverse Reactions [see Warnings and Precautions (5.6)] • Hyperammonemia  and  Encephalopathy  (Without  and  With  Concomitant  Valproic  Acid [VPA] Use) [see Warnings and Precautions (5.9)] • Kidney Stones [see Warnings and Precautions (5.10)] • Hypothermia with Concomitant Valproic Acid (VPA) Use [see Warnings and Precautions (5.11)] The data described in the following sections were obtained using topiramate tablets. 6.1 Clinical Trials Experience…

LIDODOSE (Lidocaine Hydrochloride) Gel [Gensco Laboratories, LLC]

Methemoglobinemia Cases of methemoglobinemia have been reported in association with local anesthetic use. Although all patients are at risk for methemoglobinemia, patients with glucose-6-phosphate dehydrogenase deficiency, congenital or idiopathic methemoglobinemia, cardiac or pulmonary compromise, infants under 6 months of age, and concurrent exposure to oxidizing agents or their metabolites are more susceptible to developing clinical manifestations of the condition. If local anesthetics must be used in these patients, close monitoring for symptoms and signs of methemoglobinemia is recommended. Signs and symptoms of methemoglobinemia may occur immediately or may be delayed some hours after exposure and are characterized by a cyanotic skin discoloration and abnormal coloration of the blood. Methemoglobin levels may continue to rise; therefore,…

SO TOTALLY CLEAN ANTI-BLEMISH PADS (Salicylic Acid) Liquid [ASPIRE BRANDS INC]

Out of scope – Out of scope for RxNorm and will not receive RxNorm normal forms. Out of scope information includes radiopharmaceuticals, contrast media, herbals, homeopathics, and food. Drug names that are ambiguous or not compatible with the RxNorm system, such as multivitamins with more than 4,000 characters in their names, are also out of scope. …

GUANFACINE EXTENDED-RELEASE (Guanfacine) Tablet, Extended Release [TWi Pharmaceuticals, Inc.]

Efficacy of guanfacine extended-release tablets in the treatment of ADHD was established in children and adolescents (6 to 17 years) in: Five short-term, placebo-controlled monotherapy trials (Studies 1, 2, 4, 5, and 6). One short-term, placebo-controlled adjunctive trial with psychostimulants (Study 3). One long-term, placebo-controlled monotherapy maintenance trial (Study 7). Studies 1 and 2: Fixed-dose Guanfacine Extended-Release Tablets Monotherapy Study 1 (301 study) was a double-blind, placebo-controlled, parallel-group, fixed-dose study, in which efficacy of once daily dosing with guanfacine extended-release tablets (2 mg, 3 mg and 4 mg) was evaluated for 5 weeks (n=345) in children and adolescents aged 6 to 17 years. Study 2 (304 study) was a double-blind, placebo-controlled, parallel-group,…

CIRCULATION (Cactus Grandiflorus, Kali Carbonicum, Kalmia Latifolia, Arnica Montana, Glonoinum, Ignatia Amara, Lacticum Acidum, Ranunculus Bulbosus, Alpha-Ketoglutaricum Acidum, Arsenicum Album, Fumaricum Acidum, Heart (Suis), Hepar Suis, Malicum Acidum, Natrum Oxalaceticum, Phosphorus, Strophanthus Hispidus, Spigelia Anthelmia, Carbo Vegetabilis, Naja Tripudians, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode) Liquid [Deseret Biologicals, Inc.]

Cactus Grandiflorus 3X, Kali Carbonicum 4X, Arnica Montana 6X, Lacticum Acidum 6X, Ranunculus Bulbosus 6X, alpha-Ketoglutaricum Acidum 8X, Arsenicum Album 8X, Fumaricum Acidum 8X, Glonoinum 8X, Heart (Suis) 8X, Hepar Suis 8X, Ignatia Amara 8X, Kalmia Latifolia 8X, Malicum Acidum 8X, Natrum Oxalaceticum 8X, Phosphorus 8X, Strophanthus Hispidus 8X, Spigelia Anthelmia 10X, Carbo Vegetabilis 12X, Naja Tripudians 15X, Cytomegalovirus Nosode 17X, Epstein-Barr Virus Nosode 17C. Close …

RHUMATOL (Actaea Spicata, Aesculus Hippocastanum, Arnica Montana, Bellis Perennis, Bryonia (Alba), Calcarea Carbonica, Calcarea Fluorica, Causticum, Cimicifuga Racemosa, Formicum Acidum, Ledum Palustre, Lithium Carbonicum, Magnesia Phosphorica, Phosphorus, Phytolacca Decandra, Pulsatilla (Pratensis), Rhododendron Chrysanthum, Rhus Tox, Ruta Graveolens, Salicylicum Acidum, Sepia, Zincum Metallicumk) Tablet [HelloLife, Inc.]

Actaea Spicata 10X, 300X, 200C, Aesculus Hippocastanum 10X, 300X, 200C, Arnica Montana 10X, 300X, 200C, Bellis Perennis 10X, 300X, 200C, Bryonia (Alba) 10X, 300X, 200C, Calcarea Carbonica 10X, 300X, 200C, Calcarea Fluorica 10X, 300X, 200C, Causticum 10X, 300X, 200C, Cimicifuga Racemosa 10X, 300X, 200C, Formicum Acidum 10X, 300X, 200C, Ledum Palustre 10X, 300X, 200C, Lithium Carbonicum 10X, 300X, 200C, Magnesia Phosphorica 10X, 300X, 200C, Phosphorus 10X, 300X, 200C, Phytolacca Decandra 10X, 300X, 200C, Pulsatilla (Pratensis) 10X, 300X, 200C, Rhododendron Chrysanthum 10X, 300X, 200C, Rhus Tox 10X, 300X, 200C, Ruta Graveolens 10X, 300X, 200C, Salicylicum Acidum 10X, 300X, 200C, Sepia 10X, 300X, 200C, Zincum Metallicum 10X, 300X, 200C. Close …

PREGABALIN Capsule [Major Pharmaceuticals]

6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. In all controlled and uncontrolled trials across various patient populations during the premarketing development of pregabalin, more than 10,000 patients have received pregabalin. Approximately 5,000 patients were treated for 6 months or more, over 3,100 patients were treated for 1 year or longer, and over 1,400 patients were treated for at least 2 years.Adverse Reactions Most Commonly Leading to Discontinuation in All Premarketing Controlled Clinical Studies In premarketing controlled trials of all adult populations…

DOXERCALCIFEROL Capsule [West-Ward Pharmaceuticals Corp.]

Doxercalciferol, the active ingredient in Doxercalciferol Capsules, is a synthetic vitamin D2 analog that undergoes metabolic activation in vivo to form 1α,25-dihydroxyvitamin D2 (1α,25-(OH)2D2), a naturally occurring, biologically active form of vitamin D2. Doxercalciferol is a white to off-white powder with a calculated molecular weight of 412.65 and a molecular formula of C28H44O2. It is soluble in N,N-dimethylformamide, sparingly soluble in methanol, slightly soluble in acetonitrile and practically insoluble in water. Chemically, doxercalciferol is (1α,3β,5Z,7E,22E)-9,10-Seco-ergosta-5,7,10(19),22-tetraene-1,3-diol and has the following structural formula: Other names frequently used for doxercalciferol are 1α-hydroxyvitamin D2 and 1α-hydroxyergocalciferol. Doxercalciferol Capsules are soft gelatin capsules containing 0.5 mcg, 1 mcg, or 2.5 mcg doxercalciferol for oral use. Each capsule also contains butylated hydroxyanisole…

LIDOCAINE AND PRILOCAINE Cream [Actavis Pharma, Inc.]

General: Repeated doses of lidocaine and prilocaine cream may increase blood levels of lidocaine and prilocaine. Lidocaine and prilocaine cream should be used with caution in patients who may be more sensitive to the systemic effects of lidocaine and prilocaine including acutely ill, debilitated, or elderly patients. Lidocaine and prilocaine cream should not be applied to open wounds. Care should be taken not to allow lidocaine and prilocaine cream to come in contact with the eye because animal studies have demonstrated severe eye irritation. Also the loss of protective reflexes can permit corneal irritation and potential abrasion. Absorption of lidocaine and prilocaine cream in conjunctival tissues has not been determined. If eye contact occurs, immediately…